Vor Biopharma (VOR)
US Market

Vor Biopharma (VOR) Financial Statements


Vor Biopharma Financial Overview

Vor Biopharma's market cap is currently ―. The company's EPS TTM is $-1.881; its P/E ratio is -1.02; Vor Biopharma is scheduled to report earnings on March 21, 2024, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -33.19M$ -29.98M$ -30.42M$ -24.73M$ -24.10M
EBITDA-$ -28.01M$ -30.82M$ -24.13M$ -23.21M
Net Income Common Stockholders$ -33.19M$ -29.98M$ -28.43M$ -23.91M$ -23.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 160.10M$ 186.90M$ 210.20M$ 230.25M$ 136.07M
Total Assets$ 223.02M$ 250.99M$ 277.53M$ 299.37M$ 206.37M
Total Debt$ 36.60M$ 37.51M$ 38.45M$ 38.91M$ 40.29M
Net Debt$ -123.50M$ -149.39M$ -171.75M$ -191.33M$ -95.77M
Total Liabilities$ 48.24M$ 46.54M$ 47.32M$ 48.76M$ 47.64M
Stockholders Equity$ 174.78M$ 204.45M$ 230.22M$ 250.61M$ 158.73M
Cash Flow-
Free Cash Flow-$ -24.47M$ -24.40M$ -18.67M$ -19.20M
Operating Cash Flow$ -27.90M$ -24.07M$ -24.30M$ -18.35M$ -18.90M
Investing Cash Flow$ 40.54M$ 13.64M$ 6.50M$ -97.04M$ 12.70M
Financing Cash Flow$ 176.00K$ 218.00K$ 2.52M$ 112.26M$ 4.08M
Currency in USD

Vor Biopharma Earnings and Revenue History

Vor Biopharma Debt to Assets

Vor Biopharma Cash Flow

Vor Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis